Compare SFST & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SFST | USBC |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | |
| Employees | N/A | 6 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.4M | 317.5M |
| IPO Year | 1999 | N/A |
| Metric | SFST | USBC |
|---|---|---|
| Price | $52.50 | $0.86 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $51.00 | N/A |
| AVG Volume (30 Days) | ★ 31.1K | N/A |
| Earning Date | 10-28-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.78 | N/A |
| EPS | ★ 3.23 | N/A |
| Revenue | ★ $109,391,000.00 | N/A |
| Revenue This Year | $13.23 | N/A |
| Revenue Next Year | $17.49 | N/A |
| P/E Ratio | $16.24 | ★ N/A |
| Revenue Growth | ★ 21.32 | N/A |
| 52 Week Low | $29.14 | N/A |
| 52 Week High | $52.60 | N/A |
| Indicator | SFST | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 72.07 | 52.23 |
| Support Level | $50.29 | $0.73 |
| Resistance Level | $52.60 | $0.87 |
| Average True Range (ATR) | 1.55 | 0.09 |
| MACD | 0.21 | 0.01 |
| Stochastic Oscillator | 94.68 | 72.22 |
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.